drugset / Trial / NCT02247375
Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)
RandomizedParallel-groupDouble-blindTreatment
Summary
Safety, pharmacokinetics, pharmacodynamics \[CD11b/CD18 (Mac-1) expression\] and efficacy.
Timeline
- Start
- 2000-01
- Primary completion
- 2000-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMELUBANT | Small molecule | 25 mg | Oral |
| Subject | AMELUBANT | Small molecule | 150 mg | Oral |